Ivax Articles
Galena posts 2000 results
5 April 2001
Galena changes name
30 March 2001
IVAX Corp acquires Swedish pharma firm
19 March 2001
NaPro, Abbott file for generic Taxol in USA
8 March 2001
Lilly faces first generic challenge to Zyprexa
26 February 2001
IVAX acquires epilepsy drug from Lilly
8 February 2001
Mexican government approves IVAX acquisition
8 February 2001
IVAX licenses drug for multiple sclerosis
7 December 2000
Management changes at Mylan
23 November 2000
IVAX' dispels generic Taxol delay report
17 November 2000
Call for FDA to take action on generic clozapine issue
7 November 2000
IVAX defends generic clozapine products after WSJ report
26 October 2000
B-MS drops paclitaxel lawsuit against IVAX
25 October 2000
IVAX Corp to buy Mexico's Fustery
18 October 2000
IVAX clears the way for paclitaxel launch
6 October 2000
Slight reprieve for B-MS over generic Taxol
4 October 2000
B-MS focuses on intense growth and reveals product pipeline
2 October 2000
More bad news for B-MS over Taxol
22 September 2000
IVAX gains final approval for Taxol - update
21 September 2000
Stock Commentary New York
21 September 2000
IVAX gains final approval for Taxol
18 September 2000
US Senate bill seeks to boost generics
15 September 2000
IVAX wins backing of US appellate court in Taxol patent dispute
14 September 2000
Stock Commentary New York
14 September 2000
More twists and turns in generic Taxol dispute - UPDATE
13 September 2000
More twists and turns in generic Taxol dispute
11 September 2000
Stock Commentary New York
7 September 2000
Stock Commentary New York
31 August 2000
Galena profits increase
22 August 2000
IVAX wavers on paclitaxel speculation
10 August 2000
Stock Commentary New York
10 August 2000
IVAX set to acquire Wakefield Pharma
7 August 2000
IVAX acquires Elmor of Venezuela
21 June 2000
Appointment at IVAX
8 June 2000
IVAX raises stake in Czech's Galena to 95%
30 May 2000
Stock Commentary New York
6 April 2000
Pfizer sues Ivax over Zoloft
3 April 2000
Galena posts revenue increase of 37%
14 March 2000
B-MS will hit earnings goal, despite Taxol blow
7 March 2000
B-MS Taxol patents under fire in USA
2 March 2000
Norton renegotiates GW agreement
1 February 2000
IVAX fourth quarter results to exceed expectations
20 January 2000
IVAX expects to beat analyst forecasts
22 December 1999
Appointment at IVAX Corp
2 December 1999
Stock Commentary New York
25 November 1999
Appointment at IVAX
18 November 1999
Stock Commentary New York
28 October 1999
Ivax Corp acquires IDR in Hungary
14 October 1999
Ivax launches Paxene in Czech Republic, files PLA
3 August 1999
IVAX's Paxene cleared in Europe
27 July 1999
Ivax scraps plans to buy online pharmacy stake
15 July 1999
Stock Commentary New York
15 July 1999
Generic approvals for Norton in UK
1 July 1999
Baker Norton appointment
24 June 1999
Galena 1999 investments
8 June 1999
Ivax bids for rest of Czech firm Galena
21 May 1999
Paxene cleared for KS in Czech Republic
29 March 1999
Paxene recommended for approval in EU
2 February 1999
3M patent revoked in Europe after IVAX challenge
21 January 1999
Stock Commentary New York
10 December 1998
IVAX Claims Victory In Euro Inhaler Dispute
8 December 1998
David Bethune resigns as chairman and chief executive of IVAX
22 October 1998
Norton Healthcare reduces workforce
22 October 1998
IVAX & Bigmar Sign Distribution Deal
10 September 1998
IVAX Wins In B-MS And 3M Patent Cases
28 August 1998
IVAX, Immunex File For Generic Taxol In USA
18 August 1998
US Generics Sector "Lacks Political Clout"
16 June 1998
US Generics Sector "Lacks Political Clout"
12 June 1998
IVAX Restructuring, Changing Name
27 May 1998
Changing Scene For Drugmakers In USA
14 April 1998
Collaborations And Licensing News In Brief
26 March 1998
Draxis To Acquire IVAX Manufacturing Unit
19 March 1998
Continued Roll-Out For NaPro's Paclitaxel
16 March 1998
IVAX & Goldstar Deal Terminated
14 January 1998
IVAX To Sell Soft-Gel Business To Goldstar
12 January 1998
Majors Moving Away From Acquisitions & Mergers
12 January 1998
IVAX To Sell Soft-Gel Business To Goldstar
6 January 1998
Majors Moving Away From Acquisitions & Mergers
6 January 1998
Generic Taxol Gets Tentative US Approval
2 January 1998
Appointment At Noven
18 December 1997
FDA Approves IVAX Generic Clozapine
4 December 1997
IVAX Corp: First World Approval For CFC-Free Inhaler
4 December 1997
IVAX Cuts Workforce
20 November 1997
Stock Commentary New York
13 November 1997
Generics "Marginal" In World Market
5 November 1997
Market Exclusivity Raise?Not This Year
29 October 1997
Are There Short-Term Benefits In Mega Mergers?
9 October 1997
Stock Comment New York
2 October 1997
New York Stock Comment
25 September 1997
Taxol Competitor From IVAX Nears US Market
25 September 1997
Was It Such A Good Idea To Jump Into Generics?
16 September 1997
New York Stock Comment
7 August 1997
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
